BioCardia, Inc. (NASDAQ:BCDA) Q4 2023 Earnings Call Transcript
BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.
Stay updated with breaking news from Peter Altman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.11.
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest totalling 1,010,000 shares, a growth of 927.5% from the February 29th total of 98,300 shares. Based on an average daily trading volume, of 378,600 shares, the days-to-cover ratio […]
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results March 27, 2024 BioCardia®, Inc. [Nasdaq: BCDA], a developer of...
BioCardia, Inc. (NASDAQ:BCDA – Get Free Report) CEO Peter Altman acquired 108,108 shares of the stock in a transaction that occurred on Tuesday, February 13th. The shares were acquired at an average cost of $0.46 per share, with a total value of $49,729.68. Following the transaction, the chief executive officer now owns 555,447 shares in […]
For those interested in weaving, there is a group which meets the second Tuesday of each month, Feb. 13, from 9 a.m. till noon in the Plateau Conference Room at